Beyond Generics: Tracking the 3.9% CAGR Surge in the Antihypertensive Drugs Market Driven by Advanced Formulations and Digital Health Integration.
The global Antihypertensive Drugs Market is currently valued in the multi-billion dollar range, yet it faces a significant paradox: the looming threat of patent expiration for several blockbuster drugs creates a fierce generic competition that drives down overall product pricing. Despite this downward pressure on mature segments, the market maintains a robust positive growth forecast, evidenced...
0 نظرات 0 اشتراک‌گذاری‌ها 193 مشاهدات 0 نقد و بررسی‌ها